Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19148


Purpose:

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of ascending single IV doses of ERB-257 in healthy subjects


Criteria:

Inclusion Criteria: 1. Healthy men and women of non-childbearing potential between the ages of 18 and 50. 2. Body mass index (BMI) in the range of 18.0 to 30.0 kg/m2 and body weight greater than or equal to 50 kg2. 3. Have a high probability for compliance with and completion of the study. Exclusion Criteria: 1. Presence or history of any disorder that may prevent the successful completion of the study. 2. Acute disease state (eg, nausea, vomiting, fever, or diarrhea) within 7 days before study day 1.


NCT ID:

NCT00722501


Primary Contact:

Study Director
Medical Monitor
Wyeth


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19148
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.